Analyst Ratings for Sanofi-Aventis (SNY)
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
N/A
Avg. $ Target:
N/A
| Date | Firm | Type | Rating (Past) |
PT (Past) |
Start $ | End $ | % Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 1/29/2013 | Barclays | Downgrade | Equalweight (Overweight) |
N/A (N/A) |
48.92 | 53.84 | 10.06% | Details |
| 12/14/2012 | Jefferies | Upgrade | Buy (Hold) |
N/A (N/A) |
46.90 | 53.84 | 14.8% | Details |
| 9/10/2012 | BofA/Merrill Lynch | Upgrade | Buy (Neutral) |
N/A (N/A) |
42.40 | 53.84 | 26.98% | Details |
| 8/10/2012 | Cowen | Upgrade | Outperform (Neutral) |
N/A (N/A) |
41.43 | 53.84 | 29.95% | Details |
| 8/3/2012 | Standpoint Research | Downgrade | Hold (Buy) |
N/A (N/A) |
40.02 | 53.84 | 34.53% | Details |
| 5/10/2012 | Societe Generale | New Coverage | Buy (N/A) |
N/A (N/A) |
35.92 | 53.84 | 49.89% | Details |
| 3/6/2012 | JPMorgan | Upgrade | Overweight (N/A) |
N/A (N/A) |
38.02 | 53.84 | 41.61% | Details |
| 2/1/2012 | Goldman Sachs | Downgrade | Conviction Sell (N/A) |
N/A (N/A) |
37.13 | 53.84 | 45% | Details |
| 11/8/2011 | Collins Stewart | Downgrade | Sell (N/A) |
N/A (N/A) |
33.89 | 53.84 | 58.87% | Details |
| 9/9/2011 | Credit Suisse | Downgrade | Neutral (N/A) |
N/A (N/A) |
34.10 | 53.84 | 57.89% | Details |
| 7/8/2011 | Bernstein | Upgrade | Outperform (N/A) |
N/A (N/A) |
39.64 | 53.84 | 35.82% | Details |
| 3/1/2011 | UBS | Upgrade | Buy (N/A) |
N/A (N/A) |
34.58 | 53.84 | 55.7% | Details |
